Roche has confirmed the presence of counterfeit of Pegasys PFS 180mcg/ml 0.5ml, batches B1299B03 and B3008B03 and suspected counterfeit batch B1297B11 in Germany and Romania – for more information please…
Read More
News Archive • Page 7 of 8 • Fortissa
Johnson & Johnson has been fined more than $2.2bn by US federal and State authorities for kickbacks and promotional activities of its medicines for diseases beyond their approved uses over…
McKesson is planning a $3.8bn takeover of Celesio of Germany by acquiring the controlling Haniel family’s majority stake for €23 a share and by tendering to buy the remaining shares.
Glaxo Wellcome UK Limited trading as GlaxoSmithKline UK are recalling the above batches of Imigran Injection/Subject to pharmacy, clinic and wholesaler level as a small number of syringes may have…
Following Drug Alert EL(13)A/19 a second Wockhardt manufacturing site in India has been inspected. The inspection identified deficiencies in good manufacturing practice (GMP) and the GMP certificate for this site…
The British Association of Pharmaceutical Wholesalers has called on the Department of Health (DH) to delay by one month the implementation of the Pharmaceutical Price Regulation Scheme (PPRS) which is…
Chengdu Institute of Biological Products, part of China National Biotec, is the first to win international approval from the World Health Organisation for one of its products; the live attenuated…
The world’s largest generic drug manufacturer plans to $1bn annually by the end of 2014 by cutting 5000 jobs along with other cost saving measures that will generate annual savings…
Prime Minister David Cameron has announced an extra £400m for the cancer drugs fund, which will see access to medicines paid for through the fund extended until March 2016.
Fortissa will be attending next year’s Pharmaceutical Trade Fair held from March 29th to 31st 2014 at Porte de Versailles in Paris. Please get in touch with us in order…